Prescription drug · ANDA
Lamivudine NDC 51407-866
Lamivudine 100 mg/1 · Tablet, Film coated · Oral · Golden State Medical Supply, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51407-866-60 | 5140708666051407086660 | 60 TABLET, FILM COATED in 1 BOTTLE (51407-866-60)Marketed from Jun 9, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lamivudine
- Generic name (nonproprietary)
- lamivudine
- Active ingredients
- Lamivudine — 100 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Golden State Medical Supply, Inc.NDC labeler code 51407
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 202941
- Marketing start
- Listing expires
- Other FDA classes
- Nucleoside Reverse Transcriptase Inhibitors (Mechanism)
- Identifiers
- Product ID 51407-866_3c301c61-8245-0ad5-e063-6294a90a7b71SPL ID 3c301c61-8245-0ad5-e063-6294a90a7b71SPL set ID 3c30216d-f9f5-104b-e063-6294a90af8fdRxCUI 205328UNII 2T8Q726O95
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451407086660followed by a unit qualifier and the quantityPackage 51407-0866-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Lamivudine tablets (HBV) are indicated for the treatment of chronic hepatitis B virus (HBV) infection associated with evidence of hepatitis B viral replication and active liver inflammation [ see Clinical Studies ( 14.1 , 14.2 ) ]. The following points should be considered when initiating therapy with lamivudine tablets (HBV): Due to high rates of resistance development in treated patients, initiation of treatment with lamivudine tablets (HBV) should only be considered when the use of an alternative antiviral agent with a higher genetic barrier to resistance is not available or appropriate. Lamivudine tablets (HBV) have not been evaluated in patients co-infected withhuman immunodeficiency vi…
Excerpt only. Read the full label for complete information.
About NDC 51407-866
- What is NDC 51407-866?
- 51407-866 is the product NDC for Lamivudine, Lamivudine 100 mg/1 tablet, film coated, listed with the FDA by Golden State Medical Supply, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lamivudine.
- What is the active ingredient?
- Lamivudine.
- Who is the labeler?
- Golden State Medical Supply, Inc., NDC labeler code 51407. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lamivudine?
- 23 other product NDCs are listed under this name. See all Lamivudine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lamivudine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lamivudine | Lamivudine 150 mg/1 | Tablet, Film coatedOral | Coupler LLC | 67046-1459 | 67046-1459-03 |
| Lamivudine | Lamivudine 150 mg/1 | Tablet, Film coatedOral | American Health Packaging | 60687-720 | 60687-0720-21 |
| Lamivudine | Lamivudine 150 mg/1 | Tablet, Film coatedOral | Macleods Pharmaceuticals Limited | 33342-001 | 33342-0001-09 |
| Lamivudine | Lamivudine 300 mg/1 | Tablet, Film coatedOral | Macleods Pharmaceuticals Limited | 33342-002 | 33342-0002-07 |
| lamivudine | Lamivudine 100 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-001 | 31722-0001-0231722-0001-60 |
| Lamivudine | Lamivudine 150 mg/1 | Tablet, Film coatedOral | Strides Pharma Science Limited | 64380-710 | 64380-0710-03 |
| Lamivudine | Lamivudine 300 mg/1 | Tablet, Film coatedOral | Strides Pharma Science Limited | 64380-711 | 64380-0711-04 |
| Lamivudine | Lamivudine 150 mg/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-623 | 50742-0623-60 |
| Lamivudine | Lamivudine 300 mg/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-624 | 50742-0624-60 |
| Lamivudine | Lamivudine 10 mg/mL | SolutionOral | Rising Pharma Holdings, Inc. | 57237-274 | 57237-0274-24 |
Other NDCs under ANDA 202941
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lamivudine | Lamivudine 100 mg/1 | Tablet, Film coatedOral | Apotex Corp. | 60505-3250 |